Form 8-K - Current report:
SEC Accession No. 0001213900-25-008413
Filing Date
2025-01-30
Accepted
2025-01-30 16:41:30
Documents
13
Period of Report
2025-01-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0229360-8k_longeveron.htm   iXBRL 8-K 25254
  Complete submission text file 0001213900-25-008413.txt   200001

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lgvn-20250127.xsd EX-101.SCH 3021
3 XBRL LABEL FILE lgvn-20250127_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lgvn-20250127_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0229360-8k_longeveron_htm.xml XML 3796
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 25574358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)